José Luís Passos‐Coelho

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

Robert E. Coleman, Matthew Winter, David Cameron et al. · British Journal of Cancer · 2010 · 201 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer

Mafalda Oliveira, Cristina Saura, Paolo Nucíforo et al. · Annals of Oncology · 2019 · 153 citations · Full text

Medicine, Oncology, Pharmacology +13

The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis

Sofía Braga, Ana Miranda, Rute Fonseca et al. · Psycho-Oncology · 2007 · 112 citations

Medicine, Oncology, Chemotherapy +13

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

Xavier Pivot, Andreas Schneeweiß, Shailendra Verma et al. · European Journal of Cancer · 2011 · 110 citations

Medicine, Oncology, Pharmacotherapy +9

Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.

Tai‐Lin Chen, José Luís Passos‐Coelho, D A Noe et al. · PubMed · 1995 · 103 citations

Pharmacy, Pharmacokinetics, Pharmacology +14